Press release from Companies
Published: 2026-04-07 15:46:01
SyntheticMR AB (publ) has previously announced that the Annual General Meeting 2026 would be held on Tuesday, May 12, 2026.
The Board of Directors has decided to move the meeting to Wednesday, May 27, 2026, at 18:00 CET. The meeting will take place at the company’s premises at Storgatan 11, 582 23 Linköping.
The notice and the annual report for the financial year 2025 will be published separately in the usual manner.
For more information:
Lena Åredal, CEO SyntheticMR AB
Mobile: +46 76 770 99 08
Email: lena.aredal@syntheticmr.com
SyntheticMR AB (publ) develops and markets innovative imaging solutions that enhance neuroimaging workflow efficiency and diagnostic precision. SyntheticMR’s SyMRI® solution measures brain absolute tissue properties and generates multiple contrast-weighted images, performs automatic segmentation of biomarkers, and delivers quantitative data in a single fast scan. Combinostics, a SyntheticMR company, offers the AI-powered cNeuro® suite of products that help clinicians make a difference in the lives of patients with neurological disorders. Our products are, among other things, CE-marked and FDA-approved, and we are listed on Spotlight Stock Market Exchange in Stockholm. SyntheticMR is headquartered in Linköping, Sweden, with an additional office in Tampere, Finland. For more information, please visit syntheticmr.com and combinostics.com.
